Cash Flow Statement
Growth Metrics

Biolife Solutions (BLFS) Net Income towards Common Stockholders (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Net Income towards Common Stockholders for 16 consecutive years, with $7.5 million as the latest value for Q4 2025.

  • Quarterly Net Income towards Common Stockholders fell 37.1% to $7.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$8.8 million through Dec 2025, up 35.85% year-over-year, with the annual reading at $7.5 million for FY2025, 166.88% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $7.5 million at Biolife Solutions, up from -$15.8 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $12.0 million in Q4 2024, with the low at -$72.9 million in Q2 2022.
  • Average Net Income towards Common Stockholders over 5 years is -$13.0 million, with a median of -$10.2 million recorded in 2023.
  • The sharpest move saw Net Income towards Common Stockholders skyrocketed 148.08% in 2021, then plummeted 13159.49% in 2022.
  • Over 5 years, Net Income towards Common Stockholders stood at -$15.7 million in 2021, then plummeted by 212.41% to -$49.2 million in 2022, then rose by 26.03% to -$36.4 million in 2023, then soared by 132.93% to $12.0 million in 2024, then tumbled by 37.1% to $7.5 million in 2025.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at $7.5 million, -$15.8 million, and -$448000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.